Antipsychotic Drugs Flashcards
definition of psychosis
- major mental disorder w/ following symptoms
1. personality is seriously disorganized
2. contact w/ reality is impaired
3. ability to think, perceive, and judge is impaired
4. ability to communicate and relate to others is impaired
5. can’t cope w/ environment
6. can’t meet ordinary demands of life
criteria for schizophrenia
- 2 or more, each present for a significant proportion of time for 1 month
1. delusions
2. hallucinations
3. disorganized speech
4. grossly disorganized or catatonic behavior
5. negative symptoms - social/occupational dysfunction
- at least 6 months
- substance abuse and general medical conditions have been ruled out
- in presence of autism, hallucinations or delusions present for over 1 month
positive symptoms of schizophrenia
- delusions, hallucinations, disorganized speech, disorganized or catatonic behavior
negative symptoms of schizophrenia
- impoverished thoughts
deficits of attention
blunt affect
lack of initiative
dopamine receptors
- D1 : activated by AC (Gs)
2. D2 : Gi
Typical antipsychotics MOA
- dopamine D2 blockers
- produces extrapyramidal symptoms (EPS)
- elevated PRL levels
- equally effective but differ in potency/side effects
- largely effective for positive symptoms
Atypical antipsychotics MOA
- share D2 and 5HT2A antagonism in common
- addition of 5HT2A blockade my reduce EPS and improve efficacy for negative symptoms
What are the antipsychotics
phenothiazines
thioxanthenes
butyrophenones and diphenylbutylpiperidines
Phenothiazines
- Aliphatic side chain: chlropromazine, low potency
- Piperazine group side chain: fluphenazine, perphenazine. Potent
Butyrophenones
Haloperidol - high potency
Clozapine
low potency, atypical
Risperidone
5HT2/D2 antagonist
- limited EPS at low doses
- only approved agent for use in kids and teens
Aripiprazole
D2 partial agonist - reduces actions of full agonist
- 5HT2A antagonists, 5HT1A partial agonists
- lower incidence of side effects
Ziprasidone
5HT2A, 5HT1a, 5HT2C/D2 antagonist
- limited EPS
Lurasidone
D2 and 5HT2A antagonist
5HT1A partial agonist
risk of EPS present
Neuroleptic syndrome
suppression of spontaneous movements and complex behavior
- reduced initiative and interest in environment
- decreased manifestations of emotion or affect
- psychotic symptoms disappear over time
CNS effects of antipsyhcotics
- Cerebral cortex - minimal adaptive changes in dopamine system, can lower seizure thresholds
- Basal Ganglia - initially increase DA metabolism, synthesis and firing rate. Antipsychotics don’t really occur here
- Limbic system - thought to be site of antipsychotic effects, anticholinergics don’t block therapeutic effect
- Hypothalamus - increased PRL, little tolerance, avoid in pts w/ established breast carcinoma
- Brainstem - little effect on respiration, decreased vasomotor reflexes at low doses
- CTZ -
What effect do the following have on Prl secretion?
- All typicals
- Risperidone
- Clozapine
- Olanzapine
- Ziprasidone
- Quetiapine
- Aripiprazole
- increased
- increased
- little increase
- little increase
- little increase
- no increase
- no increase